Latest Articles
Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma - OncLive
Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma OncLive
Published: April 28, 2025, 1:18 p.m.
Efficacy and Safety of Robotic Surgery With Sentinel Lymph Node Navigation in Obese Patients With Endometrial Cancer: A Retrospective Study - Cureus
Efficacy and Safety of Robotic Surgery With Sentinel Lymph Node Navigation in Obese Patients With Endometrial Cancer: A Retrospective Study Cureus
Published: April 16, 2025, 6:31 a.m.
Dr Lee on the Preliminary Safety of Nivolumab for Resectable dMMR Endometrial Cancer - OncLive
Dr Lee on the Preliminary Safety of Nivolumab for Resectable dMMR Endometrial Cancer OncLive
Published: April 14, 2025, 6:31 p.m.
Popular Meat Product Recalled In Ohio Poses Safety Risk - iHeart
Popular Meat Product Recalled In Ohio Poses Safety Risk iHeart
Published: April 10, 2025, 8:37 p.m.
Popular Meat Product Recalled In Wisconsin Poses Safety Risk - iHeart
Popular Meat Product Recalled In Wisconsin Poses Safety Risk iHeart
Published: April 9, 2025, 10:04 p.m.
How Physicians Can Stay Up-to-Date on the Legal Status, FDA Approval, & Safety of Cannabis Use - Physician's Weekly
How Physicians Can Stay Up-to-Date on the Legal Status, FDA Approval, & Safety of Cannabis Use Physician's Weekly
Published: April 9, 2025, 3:08 p.m.
Rystiggo: Safety during pregnancy, breastfeeding, and more - MedicalNewsToday
Rystiggo: Safety during pregnancy, breastfeeding, and more MedicalNewsToday
Published: April 8, 2025, 9:19 p.m.
Rystiggo: Safety during pregnancy, breastfeeding, and more - Medical News Today
Rystiggo: Safety during pregnancy, breastfeeding, and more Medical News Today
Published: April 8, 2025, 9:19 p.m.
Railroad crossing safety (March 31, 2025) - Houston Public Media
Railroad crossing safety (March 31, 2025) Houston Public Media
Published: March 31, 2025, noon
Real-World Analysis Confirms Efficacy/Safety of Dostarlimab Plus Chemotherapy in Advanced Endometrial Cancer - OncLive
Real-World Analysis Confirms Efficacy/Safety of Dostarlimab Plus Chemotherapy in Advanced Endometrial Cancer OncLive
Published: March 17, 2025, 9:22 p.m.
Link copied to clipboard!